Abstract
In purely psychogenic dermatoses, the psychiatric disorder is the primary aspect, and somatic findings arise secondarily. These are the direct consequences of psychological or psychiatric disorders. In dermatology, there are four main disorders with primarily psychiatric genesis. Disorders of Primarily Psychiatric Genesis
1. Self-inflicted dermatitis: dermatitis artefacta, dermatitis paraartefacta (disorder of impulse control), malingering
2. Dermatoses due to delusional disorders and hallucinations, such as delusions of parasitosis
3. Somatoform disorders
4. Dermatoses due to compulsive disorders
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
AWMF (2003) Leitlinie Artifizielle Störungen. http://www.AWMF-Leitlinien.de
Eckhardt A (1992) Artificial diseases (self-induced diseases) – a review. Nervenarzt 63(7): 409–415
Janus L (1972) Personality structure and psychodynamics in dermatological artefacts. Z Psychosom Med Psychoanal 18(1): 21–28
Moffaert M van (2003) The spectrum of dermatological self mutilation and self destruction including dermatitis artefacta and neurotic excoriations. In: Koo J, Lee C-S (eds) Psychocutaneous medicine. Dekker, New York
Paar GH, Eckhardt A (1987) Chronic factitious disorders with physical symptoms – review of the literature. Psychother Psychosom Med Psychol 37(6): 197–204
Arnold LM, Auchenbach MB, McElroy SL (2001) Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs 15(5): 351–359
Bach M, Bach D (1993) Psychiatric and psychometric issues in acne excoriée. Psychother Psychosom 60(3–4): 207–210
Fruensgaard K (1991) Psychotherapeutic strategy and neurotic excoriations. Int J Dermatol 30(3): 198–203
Gupta MA, Gupta AK, Haberman HF (1986) Neurotic excoriations: a review and some new perspectives. Compr Psychiatry 27: 381–386
Meigel WN, Plewig G (1976) Kauschwielen, eine Variante der Fingerknöchelpolster. Hautarzt 27(8): 391–395
Hamann K (1982) Onychotillomania treatment with pimozide. Acta Derm Venereol 62: 364–366
Koo JY, Smith LL (1991) Obsessive-compulsive disorders in the pediatric dermatology practice. Pediatr Dermatol 8(2): 107–113
Leonhard HL, Lenane MC, Swedo SE, Rettew DC, Rapoport JL (1991) A double-blind comparison of clomipramine and desipramine treatment of severe onychophagia. Arch Gen Psychiatry 48(9): 821–827
Leung AK, Robson WL (1990) Nailbiting. Clin Pediatr (Phila) 29(12): 690–692
Christenson GA, Mackenzie TB, Mitchell JE (1991) Characteristics of 60 adult chronic hair pullers. Am J Psychiatry 148: 365–370
Swedo SE, Leonard HL, Rapoport JL, Lenane MC, Goldberger EL, Cheslow DL (1989) A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 321: 497–501
Winchel RM, Jones JS, Stanley B, Molcho A, Stanley M (1992) Clinical characteristics of trichotillomania and its response to fluoxetine. J Clin Psychiatry 53: 304–308
Kind J (1993) Beitrag zur Psychodynmaik der Trichotillomanie. Prax Kinderpsychol Kinderpsychiatr 32: 53–57
Muller SA, Winkelmann RK (1972) Trichotillomania. A clinicopathologic study of 24 cases. Arch Dermatol 105: 535–540
Pioneer Clinic St. Paul, MN (1993) Trichotillomania: compulsive hair pulling. Obsessive Compulsive Foundation, Milford, CT
Pollard CA, Ibe IO, Krojanker DN, Kitchen AD, Bronson SS, Flynn TM (1991) Clomipramine treatment of trichotillomania: a follow up report on four cases. J Clin Psychiatry 52(3): 128–130
Reich S, Trüeb RM (2003) Trichoteiromanie. JDDG 1: 22–28.
Stanley MA, Swann AC, Bowers TC, Davis ML, Taylor DJ (1992) A comparison of clinical features in trichotillomania and obsessive-compulsive disorder. Behav Res Ther 30: 39–44
Vitulano LA, King RA, Scahill L, Cohen DJ (1992) Behavioral treatment of children and adolescents with trichotillomania. J Am Acad Child Adolesc Psychiatry 31: 139–146
Gieler U (2004) Leitlinien in der psychotherapeutischen Medizin: Artifizielle Störungen. JDDG 2(1): 66–73
Gieler U, Effendy I, Stangier U (1987) Kutane Artefakte: Möglichkeiten der Behandlung und ihre Grenzen. Z Hautkr 62(11): 882–890
Gupta MA, Gupta AK, Habermann HF (1987) The self-inflicted dermatoses: a critical review. Gen Hosp Psychiatry 9(1): 45–52
Harth W, Linse R (2000) Dermatological symptoms and sexual abuse: a review and case reports. J Eur Acad Dermatol Venereol 14(6): 489–494
Herpertz S, Saß H (1994) Offene Selbstschädigung. Nervenarzt 65: 296–306
Koblenzer CS (1996) Neurotic excoriations and dermatitis artefacta. Dermatol Clin 14(3): 447–455
Koblenzer CS (2000) Dermatitis artefacta. Clinical features and approaches to treatment. Am J Clin Dermatol 1: 47–55
Koo J, Lee CS (2003) Psychocutaneous medicine. Dekker, New York
Plassmann R (1995) Psychoanalysis of self injury. Schweiz Rundsch Med Prax 84: 859–865
Sachse U (1994) Selbstverletzendes Verhalten. Vandenhoeck & Ruprecht, Göttingen
Schneider G, Gieler U (2001) Psychosomatic dermatology – state of the art. Z Psychosom Med Psychother 47(4): 307–331
Willenberg H, Eckhardt A, Freyberger H, Sachsse U, Gast U (1997) Selbstschädigende Handlungen: Klassifikation und Basisdokumentation. Psychotherapeut 42: 211–217
Behrendt C, Goos M, Thiel H, Hengge UR (2001) Painful-Bruising-Syndrom. Hautarzt 52: 634–637
Frantzen E, Voigtländer V, Gerhardt H (1990) Gardner-Diamond-Syndrom. Hautarzt 41: 168–170
Gardner FH, Diamond LK (1955) Auto-erythrocyte sensitization. A form of purpura producing painful bruising following auto-sensitization to red blood cells in certain women. Blood 10: 675–690
Vakilzadeh F, Bröcker EB (1981) Syndrom der blauen Flecken. Hautarzt 32: 309–312
Meadow R (1977) Munchhausen syndrome by proxy: the hinterland of child abuse. Lancet 2: 343–345
Oostendorp I, Rakoski J (1993) Münchhausen’s Syndrom. Artefakte in der Dermatologie. Hautarzt 44: 86–90
Plassmann R (1995) Psychoanalysis of self injury. Schweiz Rundsch Med Prax 84: 859–865
Asher R (1951) Munchhausen’s syndrome. Lancet 1: 339–341
Gattaz WF, Dressing H, Hewer W (1990) Munchhausen syndrome: psychopathology and management. Psychopathology 23: 33–39
Kapfhammer HP, Rothenhausler HB, Dietrich E, Dobmeier P, Mayer C (1998) Artefactual disorders – between deception and self-mutilation. Experiences in consultation psychiatry at a university clinic. Nervenarzt 69: 401–409
Koblenzer CS (1996) Neurotic excoriations and dermatitis artefacta. Dermatol Clin 14(3): 447–455
Koblenzer CS (2000) Dermatitis artefacta. Clinical features and approaches to treatment. Am J Clin Dermatol 1: 47–55
Rothenhausler HB, Kapfhammer HP (2002) Munchhausen patients in general hospitals – clinical features and treatment approaches in C-L psychiatry settings. Psychiatr Prax 29(7): 381–387
Smith K, Killam P (1994) Munchausen syndrome by proxy. MCN Am J Matern Child Nurs 19: 214–221
Thomas K (2003) Munchausen syndrome by proxy: identification and diagnosis. J Pediatr Nurs 18: 174–180
Wojaczynska-Stanek K, Skubacz M, Marszal E (2000) Munchausen’s syndrome by proxy – a malignant form of child abuse. Pol Merkuriusz Lek 9: 799–802
AWMF (2003) Wahnstörungen http://www.AWMF-Leitlinien.de
Musalek M (1991) Der Dermatozoenwahn. Thieme, Stuttgart
Weltgesundheitsorganisation (1995): ICD-10 Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme. 10. Revision, Bd 1. Deutscher Ärzte Verlag, Köln
Hornstein OP, Hofmann P, Joraschky P (1989) Delusions of parasitic skin infestation in elderly dermatologic patients. Z Hautkr 64(11): 981–982, 985–989
Musalek M (1991) Der Dermatozoenwahn. Thieme, Stuttgart
Trabert W (1999) Shared psychotic disorder in delusional parasitosis. Psychopathology 32(1): 30–34
Damiani JT, Flowers FP, Pierce DK (1990) Pimozide in delusions of parasitosis. J Am Acad Dermatol 22: 312–313
Evans P, Merskey H (1972) Shared beliefs of dermal parasitosis: folie partagee. Br J Med Psychol 45(1): 19–26
Gieler U, Knoll M (1990) Delusional parasitosis as “folie à trois.” Dermatologica 181(2): 122–125
Koo J, Lee CS (2001) Delusions of parasitosis. A dermatologist’s guide to diagnosis and treatment. Am J Clin Dermatol 2(5): 285–290
Lee M, Koo J (2004) Pimozide: the opiate antagonist hypothesis and use in delusions of parasitosis. Dermatol Psychosom 5: 184–186
Raulin C, Rauh J, Togel B (2001) “Folie à deux” in the age of lasers. Hautarzt 52(12): 1094–1097
Bishop ER Jr (1983) Monosymptomatic hypochondriacal syndromes in dermatology. J Am Acad Dermatol 9(1): 152–158
Musalek M (1991) Der Dermatozoenwahn. Thieme, Stuttgart
Musalek, M (1991) Der Dermatozoenwahn. Thieme, Stuttgart
Raulin C, Rauh J, Togel B (2001) “Folie à deux” in the age of lasers. Hautarzt 52(12): 1094–1097
Kimata H (2002) Enhancement of allergic skin wheal responses by microwave radiation from mobile phones in patients with atopic eczema/dermatitis syndrome. Int Arch Allergy Immunol 129(4):348–350
Bullinger M (1989) Psychological effects of air pollution on healthy residents. J Environ Psych 9: 103–118
Cotterill JA (1996) Body dysmorphic disorder. Dermatol Clin 14(3): 457–463
Cullen MR (1987) The worker with multiple chemical hypersensitivities: an overview. Occup Med 2: 655–661
Eberlein-König B, Behrendt H, Ring J (2002) Idiopathische Umweltintoleranz (MCS, Öko-Syndrom) – neue Entwicklungen. Allergo J 11: 434–441
Eis D, Mühlinghaus T, Birkner N, Bullinger M, Ebel H, Eikmann T, Gieler U, Herr C, Hornberg C, Hüppe M, Lecke C, Lacour M, Mach J, Nowak D, Podoll K, Quinzio B, Renner B, Rupp T, Scharrer E, Schwarz E, Tönnies R, Traenckner-Probst I, Rose M, Wiesmüller GA, Worm M, Zunder T (2003) Multizentrische Studie zur Multiplen Chemikalien-Sensitivität (MCS) – Beschreibung und erste Ergebnisse der “RKI-Studie”. Umweltmed Forsch Prax 8:133–145
Gieler U, Bullinger M, Behrendt H, Eikmann T, Herr C, Ring J, Schwarz E, Suchenwirth R, Tretter F (1998) Therapeutische Aspekte des Multiple Chemical Sensitivity Syndroms. Umweltmed Forsch Prax 3: 3–10
Nasterlack M, Kraus T, Wrbitzky R (2002) Multiple Chemical Sensitivity. Dtsch Ärzteblatt 99: A2474–2483
Ring J, Eberlein-König B, Behrendt H (1999) “Eco-syndrome” (“multiple chemical sensitivity” – MCS). Zentralbl Hyg Umweltmed 202: 207–218
Röttgers HR (2000) Psychisch Kranke in der Umweltmedizin. Dtsch Ärzteblatt 97: A835–840
Stangier U, Gieler U (1997) Somatoforme Störungen in der Dermatologie. Psychotherapie 2: 91–101
Staudenmayer H, Selner JC, Buhr MP (1993) Double-blind provocation chamber challenges in 20 patients presenting with “multiple chemical sensitivity.” Regul Toxicol Pharmacol 18: 44–53
Tretter F (1996) Umweltbezogene funktionelle Syndrome. Int Praxis 37: 669–686
Voack C, Borelli S, Ring J (1997) Der umweltmedizinische Vier-Stufen-Plan. MMW 139: 41–44
Musalek M (1996) Wahnsyndrome in der Dermatologie. In: Gieler U, Bosse KA (Hrsg) Seelische Faktoren bei Hautkrankheiten. Huber, Bern
Rief W, Hiller W, Geissner E, Fichter M (1994) Hypochondrie: Erfassung und erste klinische Ergebnisse. Z Klin Psychol 23: 34–42
Avia MD, Ruiz MA, Olivares ME, Crespo M, Guisado AB, Sanchez A, Varela A (1996) The meaning of psychological symptoms: effectiveness of a group intervention with hypochondriacal patients. Behav Res Ther 34: 23–31
Barsky AJ (1996) Hypochondriasis. Medical management and psychiatric treatment. Psychosomatics 37: 48–56
Lupke U, Rohr W, Nutzinger D (1996) Stationäre Verhaltenstherapie bei Hypochondrie. Psychotherapeut 6: 373–384
Warwick HM, Clark DM, Cobb AM, Salkovskis PM (1996) A controlled trial of cognitive-behavioral treatment of hypochondriasis. Br J Psychiatry 169: 189–195
Altamura C, Paluello MM, Mundo E, Medda S, Mannu P (2001) Clinical and subclinical body dysmorphic disorder. Eur Arch Psychiatry Clin Neurosci 251: 105–108
Bohne A, Keuthen NJ, Wilhelm S, Deckersbach T, Jenike MA (2002) Prevalence of symptoms of body dysmorphic disorder and its correlates: a cross-cultural comparison. Psychosomatics 43: 486–490
Brosig B, Kupfer J, Niemeier V, Gieler U (2001) The “Dorian Gray Syndrome”: psychodynamic need for hair growth restorers and other “fountains of youth.” Int J Clin Pharmacol Ther 39(7): 279–283
Cash TF (1992) The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 26(6): 926–931
Cotterill JA (1996) Body dysmorphic disorder. Dermatol Clin 14(3): 457–463
Crisp AH (1981) Dysmorphophobia and the search for cosmetic surgery. Br Med J (Clin Res Ed) 282(6270): 1099–1100
Dufresne RG, Phillips KA, Vittorio CC, Wilkel CS (2001) A screening questionnaire for body dysmorphic disorder in a cosmetic dermatologic surgery practice. Dermatol Surg 27: 457–462
Gabbay V, Asnis GM, Bello JA, Alonso CM, Serras SJ, O’Dowd MA (2003) New onset of body dysmorphic disorder following frontotemporal lesion. Neurology 61(1): 123–125
Garcia-Parajua P, Martinez Vio M, Ovejero Garcia S, Caballero Martinez L (2003) Severity in dysmorphophobia: description of two cases. Actas Esp Psiquiatr 31(3): 168–170
Gupta MA, Gupta AK (2001) Dissatisfaction with skin appearance among patients with eating disorders and non-clinical controls. Br J Dermatol 145(1): 110–113
Gupta MA, Johnson AM (2000) Nonweight-related body image concerns among female eating-disordered patients and nonclinical controls: some preliminary observations. Int J Eat Disord 27(3): 304–309
Harth W, Linse R (2001) Botulinophilia: contraindication for therapy with botulinum toxin. Int J Clin Pharmacol Ther 39(10): 460–463
Hollander E, Allen A, Kwon J, Aronowitz B, Schmeidler J, Wong C, Simeon D (1999) Clomipramine vs. desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry 56(11): 1033–1039
Jorgensen L, Castle D, Roberts C, Groth-Marnat G (2001) A clinical validation of the Dysmorphic Concern Questionnaire. Aust N Z J Psychiatry 35: 124–128
Kholmogorova A, Garanjan N (2001) A combination of cognitive and psychodynamic components in the psychotherapy of somatoform disorders. Psychother Psychosom Med Psychol 51: 212–218
Koot VCM, Peeters PHM, Granath F, Grobbee DE, Nyren O (2003) Total and cause specific mortality among Swedish women with cosmetic breast implants: prospective study. BMJ 326: 527–528
McKay D (1999) Two-year follow-up of behavioral treatment and maintenance for body dysmorphic disorder. Behav Modif 23: 620–629
Niemeier V, Harth W, Kupfer J, Mayer K, Linse R, Schill WB, Gieler U (2002) Prävalenz psychosomatische Charakteristika in der Dermatologie. Hautarzt 53: 471–477
Oosthuizen P, Lambert T, Castle DJ (1998) Dysmorphic concern: prevalence and associations with clinical variables. Aust N Z J Psychiatry 32: 129–132
Otto MW, Wilhelm S, Cohen LS, Harlow BL (2001) Prevalence of body dysmorphic disorder in a community sample of women. Am J Psychiatry 158: 2061–2063
Phillips KA, Dufresne RG, Wilkel CS, Vittorio CC (2000) Rate of body dysmorphic disorder in dermatology patients. J Am Acad Dermatol 42: 436–441
Phillips KA, Albertini RS, Rasmussen SA (2002) A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry 59: 381–388
Pope HG Jr, Gruber AJ, Choi P, Olivardia R, Phillips KA (1997) Muscle dysmorphia. An underrecognized form of body dysmorphic disorder. Psychosomatics 38(6): 548–557
Porst H (2001) Manual der Impotenz. Uni-Med Science, Hamburg
Ravaldi C, Vannacci A, Zucchi T, Mannucci E, Cabras PL, Boldrini M, Murciano L, Rotella CM, Ricca V (2003) Eating disorders and body image disturbances among ballet dancers, gymnasium users and body builders. Psychopathology 36(5): 247–254
Rief W, Hiller W (1992) Somatoforme Störungen – Körperliche Symptome ohne organische Ursachen. Huber, Bern
Stangier U, Hungerbühler R, Meyer A, Wolter M (2000) Diagnostische Erfassung der körperdysmorphen Störung. Eine Pilotstudie. Nervenarzt 71(11): 876–884
Strian F (1984) Die Dysmorphophobie als Kontraindikation kosmetischer Störungen. Handchir Mikrochir Plast Chir 16: 243–245
Strumia R, Varotti E, Manzato E, Gualandi M (2001) Skin signs in anorexia nervosa. Dermatology 203(4): 314–317
Tvrdek M, Duskova M, Vrtiskova J (1998) Is there a borderline between reconstructive and aesthetic surgery? Acta Chir Plast 40(4): 91–95
Veale D, Kinderman P, Riley S, Lambrou C (2003) Self-discrepancy in body dysmorphic disorder. Br J Clin Psychol 42: 157–169
Veale D, Riley S (2001) Mirror, mirror on the wall, who is the ugliest of them all? The psychopathology of mirror gazing in body dysmorphic disorder. Behav Res Ther 39: 1381–1393
Wessells H, Lue TF, McAninch JW (1996) Complications of penile lengthening and augmentation seen at 1 referral center. J Urol 155(5): 1617–1620
Wilhelm S, Otto MW, Lohr B, Deckersbach T (1999) Cognitive behavior group therapy for body dysmorphic disorder: a case series. Behav Res Ther 37: 71–75
Busso C, Mordoh A, Llopis C, Haas R, Bello M, Woscoff A (2000) Prevalence of cutaneous manifestations in 200 patients with eating disorders. Int J Dermatol 39(5): 348–353
Choi PY, Pope HG Jr, Olivardia R (2002) Muscle dysmorphia: a new syndrome in weightlifters. Br J Sports Med 36(5): 375–376
Chung B (2001) Muscle dysmorphia: a critical review of the proposed criteria. Perspect Biol Med 44(4): 565–574
Harth W, Linse R (2002) Penisaugmentation, die dritte Ebene der körperdysmorphen Störung. Abstraktband 10. Jahrestagung, Gießen, Arbeitskreis psychosomatische Dermatologien (Sektion der DDG), S 33
Heckmann M, Ceballos-Baumann AO, Plewig G (2001) Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 344(7): 488–493
Hollander E, Aronowitz BR (1999) Comorbid social anxiety and body dysmorphic disorder: managing the complicated patient. J Clin Psychiatry 60(Suppl 9): 27–31
Kapfhammer H-P, Gündel H (Hrsg) (1997) Psychotherapie der Somatisierungsstörungen. Thieme, Stuttgart, S 104–116
Koblenzer CS (1985) The dysmorphic syndrome. Arch Dermatol 121(6): 780–784
Mayerhausen W, Vogt HJ, Fichter MM, Stahl S (1990) Dermatologic aspects of anorexia and bulimia nervosa. Hautarzt 41(9): 476–484
Neziroglu F, Stevens KP, McKay D, Yaryura-Tobias JA (2001) Predictive validity of the overvalued ideas scale: outcome in obsessive-compulsive and body dysmorphic disorders. Behav Res Ther 39: 745–756
Nierenberg AA, Phillips KA, Petersen TJ, Kelly KE, Alpert JE, Worthington JJ, Tedlow JR, Rosenbaum JF, Fava M (2002) Body dysmorphic disorder in outpatients with major depression. J Affect Disord 69: 141–148
Nissen B (2000) Hypochondria: a tentative approach. Int J Psychoanal 81: 651–666
Sass H, Wittchen H-U, Zaudig M (2001) Diagnostisches und Statistisches Manual Psychischer Störungen DSM-IV. Hogrefe, Göttingen
Schulze UM, Pettke-Rank CV, Kreienkamp M, Hamm H, Brocker EB, Wewetzer C, Trott GE, Warnke A (1999) Dermatologic findings in anorexia and bulimia nervosa of childhood and adolescence. Pediatr Dermatol 16(2): 90–94
Stangier U (2002) Hautkrankheiten und körperdysmorphe Störung. Hogrefe, Göttingen
Stangier U, Hungerbühler R, Meyer A, Wolter M, Deusinger I (1997) Depression, social anxiety and body image disturbance in body dysmorphic disorders. In: Dermatology and Psychiatry, 7th International Congress on Dermatology and Psychiatry. Abstract Book, Halle, p 13
Gieler U, Niemeier V, Kupfer J, Brosig B, Schill WB (2001) Psychosomatische Dermatologie in Deutschland. Eine Umfrage an 69 Hautkliniken. Hautarzt 52: 104–110
Huang W, Rothe MJ, Grant-Kels JM (1996) The burning mouth syndrome. J Am Acad Dermatol 34(1): 91–98
Miyaoka H, Kamijima K, Katayama Y, Ebihara T, Nagai T (1996) A psychiatric appraisal of “glossodynia.” Psychosomatics 37: 346–348
Niemeier V, Kupfer J, Harth W, Brosig B, Schill WB, Gieler U (2002) Sind Patienten mit Glossodynie psychisch unauffällig? Eine psychodiagnostisch schwer fassbare Erkrankung. Psychother Psychosom Med Psychol 52: 425–432
Pasquini M, Bitetti D, Decaminada F, Pasquini P (1997) Insecure attachment and psychosomatic skin disease. Ann Ist Super Sanita 33: 605–608
Meiss F, Fiedler E, Taube KM, Marsch WC, Fischer M (2004) Gabapentin in the treatment of glossodynia. Dermatol Psychosom 5: 17–21
Niemeier V, Kupfer J, Brosig B, Gieler U (2001) Glossodynia as an expression of a somatoform disorder – a hard-to-grasp psychodiagnostic disease? With presentation of a single case from a psychodynamic point of view. Dermatol Psychosom 2: 134–141
Ploeg HM van der, Wal N van der, Eijkman MA, Waal I van der (1987) Psychological aspects of patients with burning mouth syndrome. Oral Surg Oral Med Oral Pathol 63(6): 664–668
Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA (2003) Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 14(4): 275–291
Hoss D, Segal S (1998) Scalp dysesthesia. Arch Dermatol 134: 327–330
Kivanc-Altunay I, Savas C, Gokdemir G, Koslu A, Ayaydin EB (2003) The presence of trichodynia in patients with telogen effluvium and androgenetic alopecia. Int J Dermatol 42(9): 691–693
Rebora A, Semino MT, Guarrera M (1996) Trichodynia. Dermatology 192: 292–293
Trueb RM (1997) Trichodynie. Hautarzt 48(12): 877–880
Brähler E, Berberich H, Kupfer J (2002) Sexualität und Psychosomatik der chronischen Beckenbeschwerden des Mannes. In: Seikowski K, Starke K (Hrsg) Sexualität des Mannes. Pabst, Lengerich, S 81–90
Chakravarty K, Pharoah PD, Scott DG, Baker S (1992) Erythromelalgia – the role of hypnotherapy. Postgrad Med J 68: 44–46
Goulden V, Toomey PJ, Highet AS (1998) Successful treatment of notalgia paresthetica with a paravertebral local anesthetic block. J Am Acad Dermatol 38(1): 114–116
Katsinelos P, Kalomenopoulou M, Christodoulou K, Katsiba D, Tsolkas P, Pilpilidis I, Papagiannis A, Kapitsinis I, Vasiliadis I, Souparis T (2001) Treatment of proctalgia fugax with Botulinum A toxin. Eur J Gastroenterol Hepatol 13(11): 1371–1373
Krege S, Ludwig M, Kloke M, Rubben H (2003) Chronic pain syndrome in urology. Urologe A 42(5): 669–674
Sasaki K, Smith CP, Chuang YC, Lee JY, Kim JC, Chancellor MB (2001) Oral gabapentin (Neurontin) treatment of refractory genitourinary tract pain. Tech Urol 7(1): 47–49
Scialli AR (1999) Evaluating chronic pelvic pain. A consensus recommendation. Pelvic Pain Expert Working Group. J Reprod Med 44(11): 945–952
Stewart DE, Reicher AE, Gerulath AH, Boydell KM (1994) Vulvodynia and psychological distress. Obstet Gynecol 84: 587–590
Wesselmann U, Burnett AL, Heinberg LJ (1997) The urogenital and rectal pain syndromes. Pain 73(3): 269–294
Bodden-Heidrich R, Kuppers V, Beckmann MW, Ozornek MH, Rechenberger I, Bender HG (1999) Psychosomatic aspects of vulvodynia. Comparison with the chronic pelvic pain syndrome. J Reprod Med 44(5): 411–416
Edwards L (2003) New concepts in vulvodynia. Am J Obstet Gynecol 189(Suppl 3): 24–30
Luzzi GA (2002) Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis and management. J Eur Acad Dermatol Venereol 16(3): 253–256
Pukall CF, Payne KA, Binik YM, Khalife S (2003) Pain measurement in vulvodynia. J Sex Marital Ther 29(Suppl 1): 111–120
Zermann DH, Ishigooka M, Doggweiler R, Schmidt RA (1999) Neurourological insights into the etiology of genitourinary pain in men. J Urol 161(3): 903–908
Arnetz B, Fjellner BB (1985) Psychological predictors of pruritus during mental stress. Acta Derm Venereol 65: 504–508
Bienenstock J, MacQueen G, Sestini P, Marshall JS, Stead RH, Perdue MH (1991) Mast cell/nerve interactions in vitro and in vivo. Am Rev Respir Dis 143: 55–58
Gupta MA, Gupta MK, Kirkby S, Weiner HK, Mace TM, Schorck NJ, Johnson EH, Ellis CN, Vorhees JJ (1989) Pruritus in psoriasis: a prospective study of some psychiatric and dermatologic correlates. Arch Dermatol 124: 1052–1057
Gupta MA, Gupta AK, Schork NJ, Ellis CN (1994) Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 56: 36–40
Handwerker H (1993) Neurophysiologische Mechanismen des Juckens. Z Hautkr 68: 730–735
Handwerker H (1998) Pathophysiologie des Juckreizes. In: Garbe C, Rassner G (Hrsg) Dermatologie – Leitlinien und Qualitätssicherung für Diagnostik und Therapie. Springer, Berlin, S 43–45
Luger TA, Lotti T (1998) Neuropeptides: role in inflammatory skin diseases. J Eur Acad Dermatol Venerol 10: 207–212
Magerl W (1991) Neurophysiologie des Juckens. Allergologie 14: 395–405
Metze D, Reimann S, Szepfalusi Z, Bohle B, Kraft D, Luger TA (1997) Persistent pruritus after hydroxyethyl starch infusion therapy: a result of long-term storage in cutaneous nerves. Br J Dermatol 136: 553–559
Musalek M (1991) Der Dermatozoenwahn. Thieme, Stuttgart
Naukkarinen A, Harvima IT, Aalto Ml, Harvima RJ, Horshmanheimo M (1991) Quantitative analysis of contact sites between mast cells and sensory nerves in cutaneous psoriasis and lichen planus based on a histochemical double staining technique. Arch Dermatol Res 283: 433–437
Niemeier V, Kupfer J, Gieler U (2000) Observations during an itch-inducing lecture. Dermatol Psychosom 1: 15–18
Rechenberger I (1981) Pruritus as a psychic phenomenon. MMW Munch Med Wochenschr 123(24): 1005–1006
Russell M, Dark KA, Cummins RW, Ellman G, Callaway E, Peeke HVS (1984) Learned histamine release. Science 225: 733–734
Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjörk HE (1997) Specific C-receptors for itch in human skin. J Neurosci 17: 8003–8008
Scholz OB, Hermanns N (1994) Krankheitsverhalten und Kognitionen beeinflussen die Juckreiz-Wahrnehmung von Patienten mit atopischer Dermatitis! Z Klin Psychol 23: 127–135
Schultz-Amling W, Köhler-Weisker A (1996) Pruritus ani. In: Gieler U, Bosse KA (Hrsg) Seelische Faktoren bei Hautkrankheiten, 2. Aufl. Huber, Bern, S 105–112
Sheehan-Dare RA, Henderson MJ, Cotterill JA (1990) Anxiety and depression in patients with chronic urticaria and generalized pruritus. Br J Dermatol 123: 769–774
Shelley WB, Shelley ED (1985) Adrenergic urticaria: a new form of stress-induced hives. Lancet 9;2(8463): 1031–1033
Shelley WB, Shelley ED (1998) Aquadynia: noradrenergic pain induced by bathing and responsive to clonidine. J Am Acad Dermatol 38: 357–358
Williams RM, Bienenstock J, Stead RH (1995) Mast cells: the neuroimmune connection. Chem Immunol 61: 208–235
Goulden V, Toomey PJ, Highet AS (1998) Successful treatment of notalgia paresthetica with a paravertebral local anesthetic block. J Am Acad Dermatol 38: 114–116
Rief W, Hiller W (1992) Somatoforme Störungen. Huber, Bern
Hollander E, Greenwald S, Neville D, Johnson J, Hornig CD, Weissman MM (1997) Uncomplicated and comorbid obsessive-compulsive disorder in an epidemiologic sample. Depress Anxiety 4(3): 111–119
Phillips KA (1996) Body dysmorphic disorder. Diagnosis and treatment of imagined ugliness. J Clin Psychiatry 57(8): 61–64
McElroy SL, Phillips KA, Keck PE (1994) Obsessive compulsive spectrum disorder. J Clin Psychiatry 55(suppl 10): 33–51
Riddle M (1998) Obsessive compulsive disorder in children and adolescents. Br J Psychiatry 173(suppl 35): 91–96
Sieg J, Scholz OB (2001) Subjektives Gefühls- und Körpererleben bei Wasch- und Kontrollzwangshandlungen. Verhaltenstherapie 11: 288–296
Steketee GS, Grayson JB, Foa EB (1985) Obsessive-compulsive disorder: differences between washers and checkers. Behav Res Ther 23: 197–201
Phillips KA (1996) Body dysmorphic disorder. Diagnosis and treatment of imagined ugliness. J Clin Psychiatry 57(8): 61–64
Rosenbaum MS, Ayllon T (1981) The behavioral treatment of neurodermatitis through habit-reversal. Behav Res Ther 19: 313–318
Simeon D, Hollander E, Stein DJ, Cohen L, Aronowitz B (1995) Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. Am J Psychiatry 152(8): 1207–1209
Stein DJ, Hollander E (1992) Dermatology and conditions related to obsessive-compulsive disorder. J Am Acad Dermatol 26: 237–242
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2009). Primarily Psychogenic Dermatoses. In: Clinical Management in Psychodermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-34719-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-540-34719-4_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-34718-7
Online ISBN: 978-3-540-34719-4
eBook Packages: MedicineMedicine (R0)